133 related articles for article (PubMed ID: 29216393)
21. Lifetime attributable risk of radiation induced second primary cancer from scattering and scanning proton therapy - A model for out-of-field organs of paediatric patients with cranial cancer.
Dell'Oro M; Short M; Wilson P; Peukert D; Hua CH; Merchant TE; Bezak E
Radiother Oncol; 2022 Jul; 172():65-75. PubMed ID: 35504365
[TBL] [Abstract][Full Text] [Related]
22. Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status.
Takam R; Bezak E; Marcu LG; Yeoh E
Radiat Res; 2011 Oct; 176(4):508-20. PubMed ID: 21756083
[TBL] [Abstract][Full Text] [Related]
23. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.
Abramson DH; Frank CM
Ophthalmology; 1998 Apr; 105(4):573-9; discussion 579-80. PubMed ID: 9544627
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.
Joosten A; Matzinger O; Jeanneret-Sozzi W; Bochud F; Moeckli R
Radiother Oncol; 2013 Jan; 106(1):33-41. PubMed ID: 23351844
[TBL] [Abstract][Full Text] [Related]
25. Scattered dose to radiosensitive organs and associated risk for cancer development from head and neck radiotherapy in pediatric patients.
Kourinou KM; Mazonakis M; Lyraraki E; Stratakis J; Damilakis J
Phys Med; 2013 Nov; 29(6):650-5. PubMed ID: 22921884
[TBL] [Abstract][Full Text] [Related]
26. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
27. Development of clinical application program for radiotherapy induced cancer risk calculation using Monte Carlo engine in volumetric-modulated arc therapy.
Kang DJ; Shin YJ; Jeong S; Jung JY; Lee H; Lee B
Radiat Oncol; 2021 Jun; 16(1):108. PubMed ID: 34118968
[TBL] [Abstract][Full Text] [Related]
28. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.
Matsumoto S; Yonai S; Bolch WE
Med Phys; 2019 Dec; 46(12):5824-5832. PubMed ID: 31603561
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo simulation of a typical 60Co therapy source.
Mora GM; Maio A; Rogers DW
Med Phys; 1999 Nov; 26(11):2494-502. PubMed ID: 10587239
[TBL] [Abstract][Full Text] [Related]
30. Imaging doses and secondary cancer risk from kilovoltage cone-beam CT in radiation therapy.
Kim DW; Chung WK; Yoon M
Health Phys; 2013 May; 104(5):499-503. PubMed ID: 23532078
[TBL] [Abstract][Full Text] [Related]
31. Organ S values and effective doses for family members exposed to adult patients following I-131 treatment: a Monte Carlo simulation study.
Han EY; Lee C; Mcguire L; Brown TL; Bolch WE
Med Phys; 2013 Aug; 40(8):083901. PubMed ID: 23927361
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Organ and Effective Photon Dose Coefficients for Reference Phantoms in Articulated and Upright Postures in Cranial and Caudal Irradiation Geometries.
Bales K; Dewji S
Health Phys; 2019 May; 116(5):599-606. PubMed ID: 30624352
[TBL] [Abstract][Full Text] [Related]
33. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
[TBL] [Abstract][Full Text] [Related]
34. Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study.
Mesbahi A; Seyednejad F; Gasemi-Jangjoo A
Jpn J Radiol; 2010 Jun; 28(5):398-403. PubMed ID: 20585932
[TBL] [Abstract][Full Text] [Related]
35. Evaluation based on Monte Carlo simulation of lifetime attributable risk of cancer after neck X-ray radiography.
Seo D; Han S; Kim KH; Kim J; Park K; Lim H; Kim J
Radiol Med; 2015 Nov; 120(11):1043-9. PubMed ID: 25920438
[TBL] [Abstract][Full Text] [Related]
36. Concomitant Imaging Dose and Cancer Risk in Image Guided Thoracic Radiation Therapy.
Zhang Y; Wu H; Chen Z; Knisely JP; Nath R; Feng Z; Bao S; Deng J
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):523-31. PubMed ID: 26460994
[TBL] [Abstract][Full Text] [Related]
37. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
38. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk.
Murray T
Surv Ophthalmol; 1998; 43(3):288-9. PubMed ID: 9862317
[No Abstract] [Full Text] [Related]
39. Comparing risk estimates following diagnostic CT radiation exposures employing different methodological approaches.
Kashcheev VV; Pryakhin EA; Menyaylo AN; Chekin SY; Ivanov VK
Health Phys; 2014 Jun; 106(6):806-11. PubMed ID: 24776915
[TBL] [Abstract][Full Text] [Related]
40. Tumour size can have an impact on the outcomes of epidemiological studies on second cancers after radiotherapy.
Schneider U; Walsh L; Newhauser W
Radiat Environ Biophys; 2018 Nov; 57(4):311-319. PubMed ID: 30171348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
